Last Close
May 21  •  04:00PM ET
80.07
Dollar change
+0.36
Percentage change
0.45
%
May 20, 4:25 PMZoetis Board declares third-quarter 2026 dividend of $0.53 per share, payable September 1, 2026 to shareholders of record on July 20, 2026.
Index
S&P 500
P/E
13.27
EPS (ttm)
6.04
Insider Own
0.57%
Shs Outstand
420.35M
Perf Week
6.08%
Market Cap
33.57B
Forward P/E
10.77
EPS next Y
7.43
Insider Trans
-0.35%
Shs Float
416.85M
Perf Month
-31.87%
Enterprise Value
40.86B
PEG
1.38
EPS next Q
1.87
Inst Own
101.58%
Perf Quarter
-37.82%
Income
2.64B
P/S
3.53
EPS this Y
8.07%
Inst Trans
4.82%
Perf Half Y
-32.22%
Sales
9.51B
P/B
10.41
EPS next Y
7.30%
ROA
18.07%
Perf YTD
-36.36%
Book/sh
7.69
P/C
17.29
EPS next 5Y
7.78%
ROE
67.01%
52W High
172.23 -53.51%
Perf Year
-50.40%
Cash/sh
4.63
P/FCF
15.72
EPS past 3/5Y
10.25% 11.96%
ROIC
21.19%
52W Low
72.38 10.62%
Perf 3Y
-55.41%
EV/EBITDA
10.07
Sales past 3/5Y
5.42% 7.24%
Gross Margin
70.43%
Volatility
4.90% 3.89%
Perf 5Y
-54.51%
EV/Sales
4.30
EPS Y/Y TTM
8.35%
Oper. Margin
37.57%
ATR (14)
4.22
Perf 10Y
70.14%
Quick Ratio
1.91
Sales Y/Y TTM
2.40%
Profit Margin
27.79%
RSI (14)
26.03
Current Ratio
3.15
EPS Q/Q
1.02%
SMA20
-15.49%
Beta
0.81
Debt/Eq
2.86
Sales Q/Q
1.89%
SMA50
-26.31%
Rel Volume
1.59
Prev Close
79.71
Employees
14500
LT Debt/Eq
2.86
SMA200
-37.31%
Avg Volume
5.39M
Price
80.07
IPO
Feb 01, 2013
Option/Short
Yes / Yes
Trades
Volume
8,564,827
Change
0.45%
Date Action Analyst Rating Change Price Target Change
Apr-15-26Initiated Citigroup Buy $145
Jan-22-26Downgrade Piper Sandler Overweight → Neutral $135
Dec-15-25Downgrade BofA Securities Buy → Neutral $135
Dec-09-25Initiated Barclays Equal Weight $136
Nov-21-25Initiated KeyBanc Capital Markets Sector Weight
Jul-17-25Downgrade Leerink Partners Outperform → Market Perform $155
Jun-18-25Downgrade Stifel Buy → Hold $160
Dec-02-24Initiated Leerink Partners Outperform $215
Jul-25-24Initiated BTIG Research Buy $220
Jan-12-24Reiterated Stifel Buy $195 → $215
May-21-26 08:30AM
May-20-26 04:15PM
May-11-26 04:30PM
May-07-26 08:45PM
04:30PM
12:09PM Loading…
12:09PM
11:47AM
07:59AM
07:59AM
07:08AM
07:00AM
Apr-16-26 09:47AM
Apr-15-26 09:47AM
Apr-02-26 08:30AM
Mar-23-26 01:38PM
04:19AM Loading…
Mar-16-26 04:19AM
Mar-14-26 02:49PM
Mar-12-26 08:30AM
Mar-06-26 09:40AM
09:30AM
07:54AM
Mar-05-26 08:30AM
Mar-02-26 07:00AM
04:07AM
Mar-01-26 05:06AM
Feb-27-26 04:51PM
11:00AM
05:29AM
Feb-26-26 11:03PM
Feb-24-26 04:22PM
09:50AM Loading…
09:50AM
08:30AM
Feb-23-26 10:57AM
Feb-19-26 12:38AM
Feb-18-26 10:05AM
09:40AM
04:01AM
Feb-13-26 04:57PM
07:13AM
12:35AM
Feb-12-26 04:15PM
04:05PM
01:24PM
12:32PM
10:30AM
09:30AM
08:45AM
08:10AM
07:46AM
07:38AM
07:05AM
07:00AM
05:36AM
04:50AM
Feb-10-26 10:09PM
10:00AM
Feb-09-26 11:30AM
10:22AM
09:15AM
08:55AM
Feb-06-26 08:57AM
Feb-05-26 04:15PM
12:22PM
10:00AM
09:50AM
Feb-04-26 02:18PM
Feb-03-26 06:15PM
11:40AM
10:00AM
09:45AM
08:14AM
Jan-31-26 12:35PM
Jan-30-26 09:40AM
Jan-28-26 06:15PM
Jan-27-26 04:04PM
08:55AM
Jan-26-26 04:27PM
Jan-23-26 09:41AM
Jan-22-26 01:25PM
12:20PM
12:10PM
09:37AM
08:55AM
Jan-20-26 10:35PM
Jan-16-26 09:25AM
Jan-12-26 06:15PM
04:52PM
09:22AM
Jan-07-26 02:11PM
11:40AM
Dec-31-25 09:15AM
Dec-30-25 05:52PM
08:30AM
Dec-28-25 02:17AM
Dec-23-25 04:16PM
Dec-22-25 06:15PM
Dec-19-25 03:34PM
07:45AM
Dec-18-25 08:30AM
Dec-17-25 05:00PM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
CEO & DirectorMs. Kristin C. Peck
Executive VP & CFOMr. Wetteny N. Joseph CPA
Executive VPMs. Roxanne Lagano
Scientific AdvisorDr. Robert J. Polzer Ph.D.
Executive VP & Chief Commercial OfficerMr. Jamie Brannan
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMELIO FRANK ADirectorMay 13 '26Buy75.396,650501,34421,458May 13 04:35 PM
Bisaro PaulDirectorMay 13 '26Buy75.882,000151,75027,862May 13 04:35 PM
MCCALLISTER MICHAEL BDirectorMay 11 '26Buy77.763,000233,27324,524May 12 07:26 PM
PECK KRISTIN CChief Executive OfficerFeb 17 '26Option Exercise41.8320,000836,600121,337Feb 17 04:22 PM
PECK KRISTIN CChief Executive OfficerFeb 17 '26Sale127.0520,0002,540,964101,337Feb 17 04:22 PM
Polzer Robert JOfficerFeb 17 '26Proposed Sale127.342,346298,742Feb 17 04:14 PM
PECK KRISTIN COfficerFeb 17 '26Proposed Sale127.0520,0002,540,964Feb 17 04:13 PM
Polzer Robert JOfficerFeb 13 '26Proposed Sale129.093,662472,728Feb 13 04:26 PM
Lagano RoxanneExecutive Vice PresidentJun 03 '25Sale170.00652110,84015,129Jun 04 04:31 PM
Lagano RoxanneOfficerJun 03 '25Proposed Sale170.00652110,840Jun 03 04:22 PM